Department of the Army December 29, 2009 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning an Anti-Relapse Treatment and Prophylaxis for Malaria
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/261,872 entitled ``* * * as an Anti-Relapse Treatment and Prophylaxis for Malaria,'' filed November 17, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Army Science Board Plenary Meeting
Pursuant to the Federal Advisory Committee Act (FACA) of 1972 (5 U. S. C., Appendix, as amended), the Sunshine in the Government Act of 1976 (U. S. C. 552b, as amended) and 41 Code of the Federal Regulations (CFR 102-3. 140 through 160, the Department of the Army announces the following committee meeting:
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.